Carriage of Neisseria meningitidis by Greek children: risk factors and strain characteristics  by Pavlopoulou, I.D. et al.
ORIGINAL ARTICLE
Carriage of Neisseria meningitidis by Greek children: risk factors and strain
characteristics
I. D. Pavlopoulou1, G. L. Daikos2, H. Alexandrou3, E. Petridou3, A. Pangalis3, M. Theodoridou1
and V. P. Syriopoulou1
1First Department of Paediatrics; 2First Department of Propaedeutic Medicine, Athens University and
3Microbiology Department, Aghia Sophia Children’s Hospital, Athens, Greece
ABSTRACT
Oropharyngeal swabs were cultured from 554 children aged 2–19 years attending nurseries, primary
schools and secondary schools in the central Athens area. A questionnaire was completed to identify risk
factors for carriage. Susceptibility to antimicrobial agents was determined by Etest. The genetic
relatedness of the strains was examined by pulsed-ﬁeld gel electrophoresis (PFGE), and isolate
serogrouping was performed by slide agglutination. Twenty-two (4%) children were carriers of Neisseria
meningitidis; seven isolates belonged to serogroup C, and ﬁve to serogroup B. One isolate was resistant to
co-trimoxazole, and ﬁve showed intermediate resistance to penicillin. DNA analysis of 16 isolates
revealed six distinct PFGE patterns. Clusters with indistinguishable PFGE patterns were noted in the
same school. More than one serogroup was included in the same clonal group. On multivariate logistic
regression analysis, only age > 12 years remained independently associated with the carrier state (odds
ratio, 7.96; 95% CI, 2.24–28.33; p < 0.001). Overall, the N. meningitidis carriage rate among Greek
schoolchildren increased with age, and the predominant serogroups in the Athens region were groups C
and B. These ﬁndings may have important implications for future immunisation strategies with
conjugate vaccines.
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INTRODUCTION
Meningococcal disease remains a major cause of
child morbidity and mortality worldwide, despite
improved diagnosis and treatment. The usual
sources of meningococcal infection are asympto-
matic human nasopharyngeal carriers. The rate of
Neisseria meningitidis carriage varies from <2% in
young children, to 5–15% in teenagers and young
adults, to c. 50% in people who live in severely
overcrowded conditions such as institutions and
military camps [1–3]. The meningococcal carrier
state is an immunising process, and production of
serogroup-speciﬁc antibodies to meningococci
can usually be identiﬁed within 2 weeks of
colonisation [2,4]. Preceding viral infection, active
or passive smoking, male sex and low socio-
economic status have been described as predis-
posing factors for meningococcal carriage [2,5,6].
According to epidemiological studies, when the
carrier rate exceeds 20%, the community is in
danger of an epidemic, usually caused by the
predominant carrier serogroup [7]. However, it
should be stressed that many epidemics occur not
at times of high pharyngeal carriage, but when
the rates of acquisition of infection are increasing,
and particularly in persons newly infected with
the organism [4].
In Greece, N. meningitidis is the leading cause of
bacterial meningitis in children, with an estimated
incidence of 7.5 cases ⁄ 100 000 children aged
< 14 years in the metropolitan Athens area [8].
Most children affected are aged 2–5 years.
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A second group that is often affected comprises
teenagers [9]. Since 1993, there has been an
increase in the number of cases of meningococcal
disease, with serogroup B being predominant, but
in the years 1996 and 1997, serogroup C was
isolated in the majority of cases. At present,
serogroup B accounts for 58% of the cases in
Greece. This increased prevalence partly reﬂects
improved reporting to the National Meningitis
Reference Laboratory, but is also associated with
the introduction of new strains, e.g., phenotype
C:2a:P1.2.P1.5 (clone ET-37) initially, and subse-
quently phenotype B:2a:P1,2 (clone ET-15) [10,11].
Previous studies conducted among military
recruits, schoolchildren and ethnic immigrants
in the greater Athens area have identiﬁed men-
ingococcal carriage rates of 25%, 5.8% and 13%,
respectively [11,12]. Immunisation strategies,
until recently, included targeted vaccination in
localised outbreaks and vaccination of military
recruits with the meningococcal A + C polysac-
charide vaccine currently available in Greece.
However, widespread acceptance since January
2001, by both paediatricians and parents, of the
newly licensed conjugate meningococcal C vac-
cine has led to increasing pressure on the Greek
Ministry of Health to include this vaccine in the
National Immunisation Schedule, despite its great
cost.
The aim of the present study was to determine
meningococcal carriage rates among schoolchil-
dren in the central Athens area, and to identify
the risk factors associated with the carrier state.
The characteristics of the isolates obtained are also
described, with possible implications for the
future prevention of meningococcal disease in
Greece.
MATERIALS AND METHODS
Subjects
In total, 580 children aged 2–19 years, who were attending
three day-care nurseries (two classrooms each), one primary
school (ten classrooms) and one secondary school (15 class-
rooms) in the central Athens area, participated in this study.
These schools were randomly selected from 39 nurseries, 275
primary schools and 112 secondary schools serving the area of
the study. Parents were informed by letter and asked to
complete a questionnaire as consent for their children to
participate in the survey. Questions included age, sex, nation-
ality, preceding viral infection and antibiotic use within the
past month, parental smoking and educational level, house-
hold density ratio (calculated from the ratio of household
members to the number of rooms in the house), breast-feeding,
and previous administration of either polysaccharide or
conjugated meningococcal vaccine. Oropharyngeal swabs
were collected by a single physician from these children in
their classrooms between November 2000 and February 2001.
Bacterial identiﬁcation
The swabs were immediately plated on chocolate agar with
vancomycin, colistin and neomycin. Plates were incubated at
35 C in CO2 5% v ⁄v for 2 days, after which meningococci
were identiﬁed by standard microbiological methods. MICs of
penicillin G, chloramphenicol, rifampicin, ceftriaxone and
trimethoprim–sulphamethoxazole were determined by Etest
on Mueller–Hinton agar with horse blood 5% v ⁄v. Isolates
were classiﬁed as resistant, intermediately resistant or sensi-
tive to penicillin if the MICs were ‡ 1 mg ⁄L, 0.125–0.5 mg ⁄L, or
< 0.125 mg ⁄L, respectively. Resistance to co-trimoxazole,
chloramphenicol and rifampicin was deﬁned as an MIC of
‡ 2 mg ⁄L, ‡ 2 mg ⁄L and ‡ 4 mg ⁄L, respectively [13].
Serogrouping
Monoclonal and polyclonal sera for groups A, B, C, D, Y and
W135 were used to determine the serogroups of the meningo-
coccal isolates by a slide agglutination technique as recom-
mended by the manufacturer (Biotec Laboratories, Ipswich,
UK). N. meningitidis colonies were subcultured and preserved
at )70 C for further genetic analysis.
Pulsed-ﬁeld gel electrophoresis (PFGE)
The relatedness between strains was examined by PFGE of
NotI and SﬁI digests of genomic DNA as described previously
[14]. In brief, N. meningitidis isolates were grown overnight on
blood agar plates, harvested and resuspended in 2 mL of PIV
buffer (1 M NaCl, 10 mM Tris-HCl, pH 7.6). An equal volume
of low-melting-point agarose (Bio-Rad Laboratories, Rich-
mond, CA, USA) was added, mixed, and pipetted into a plug
mould. Bacteria were lysed by placing the plugs in 5 mL of
fresh lysis solution (6 mM Tris-HCl, pH 7.6, 1 M NaCl, 100 mM
EDTA, pH 7.5, Brij-58 0.5% w ⁄v, deoxycholate 0.2% w ⁄v,
sodium lauroyl sarcosine 0.5% w/v, RNase 20 lg ⁄mL, and
lysozyme 1 mg ⁄mL). Following incubation overnight at 37 C,
this solution was replaced with 5 mL of ESP buffer (0.5 M
EDTA, pH 9–9.5, sodium lauroyl sarcosine 1% w ⁄v, protein-
ase K 50 lg ⁄mL) and incubated overnight at 50 C. The plugs
were washed with TE buffer (10 mM Tris-HCl, pH 7.5, 0.1 mM
EDTA), digested with NotI and SﬁI separately, and loaded into
the wells of an agarose 0.8% w ⁄v gel. PFGE was performed
with clamped homogeneous electric ﬁelds (CHEF-DRIII sys-
tem; Bio-Rad), stained in ethidium bromide, and photo-
graphed.
Statistical analysis
The questionnaire data were analysed with the STATA
statistical package (Stata Corporation, College Station, TX,
USA). The chi-square test was used to test the association
between each of the risk factors and meningococcal carriage.
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Variables that were statistically signiﬁcant at a 10% level
were analysed with multiple logistic regression to identify
factors that were independently associated with meningo-
coccal carraige. Crude and adjusted odds ratios and 95%
conﬁdence intervals are presented when appropriate.
RESULTS
Swabs were taken from 554 of 580 pupils attending
the schools in the study (response rate of 95.5%)
who consented and returned completed question-
naires. The children were aged 2–19 years (mean
age, 10 years; SD, ± 4 years). N. meningitidis was
isolated from 22 swabs, giving an overall carriage
rate of 3.97%. Among the 349 children aged
< 12 years, only three (0.86%) carriers were iden-
tiﬁed. Above the age of 12 years, the carriage
rate increased signiﬁcantly to 9.27% (19 ⁄ 205;
p < 0.0001). The carrier state did not differ sig-
niﬁcantly between the sexes (13 of 272 male and
nine of 282 female carriers) (Table 1).
Factors associated with meningococcal carriage
are shown in Table 2. Preceding viral infection
and recent antibiotic use were inversely related to
meningococcal carriage (p0.008 and p0.094,
respectively). Children living in densely popu-
lated households were more likely to be carriers
(p0.054). No association with exposure to passive
smoking was detected. Nationality and breast-
feeding were not associated signiﬁcantly with
meningococcal carriage, nor was previous vaccin-
ation with conjugate meningococcal C or poly-
saccharide A + C vaccine. The carriage rate was
lower among children whose parents had univer-
sity-level education compared to those whose
parents had not attended university (p0.039).
Following multivariate logistic regression
analysis, only age remained a statistically import-
ant risk factor. Being aged > 12 years increased
the risk of being a carrier by more than eight-
fold compared to children aged £ 12 years
(Table 3).
All isolates were sensitive to ceftriaxone, rif-
ampicin and chloramphenicol. Only one (4.5%)
isolate was resistant to co-trimoxazole, while ﬁve
(22.7%) showed intermediate resistance to peni-
cillin. Five serogroups were represented: sero-
groups A (one isolate, 4.5%), B (ﬁve isolates,
22.7%), C (seven isolates, 31.8%), D (one isolate,
4.5%), and W135 (three isolates, 13.7%). Five
(22.7%) isolates were non-serogroupable.
Analysis of NotI and SﬁI digests of genomic
DNA from 16 N. meningitidis isolates revealed six
PFGE patterns, with 14 of the isolates in four
groups: group a, eight isolates; group b, two
isolates; group c, two isolates; and group d, two
isolates. The remaining two isolates had distinct
PFGE patterns that were not related to each other
or to any of the other groups. Four isolates were
not alive at the time when PFGE was performed,
and two failed to give any pattern (Table 4). When
the isolates from carriers were compared with four
randomly selected N. meningitidis isolates from
cerebrospinal ﬂuid (two of which belonged to
serogroup B and two to serogroup C) from
children who had meningitis at the same time, it
was found that the pathogenic isolates of sero-
groups B and C had identical PFGE patterns to
those of carrier PFGE groups a and b, respectively.
DISCUSSION
The data presented in this report provide infor-
mation on meningococcal carriage among Greek
schoolchildren and on the genotypic and pheno-
typic characteristics of N. meningitidis isolates in
the geographical region studied. The resulting
small number of meningococcal carriers and the
size of the study limit the use of the data when
considering national immunisation policy. How-
ever, the ﬁndings may have implications for
future immunisation with meningococcal conju-
gate vaccine if combined with additional studies
from other parts of the country.
Estimating the rates of carriage across different
groups within a community at any one time is
difﬁcult, because several factors related to the
host, microorganism or swabbing technique may
Table 1. Meningococcal carriage in Greek schoolchildren
by age, sex and ethnic origin
Variable
Carriage
Positive/total % p
Age
£ 12 years 3 ⁄ 349 0.86
> 12 years 19 ⁄ 205 9.2 < 0.0001
Sex
Male 13 ⁄ 272 4.7
Female 9 ⁄ 282 3.1 0.339
Nationality
Greek 20 ⁄ 511 3.9
Immigrant 2 ⁄ 43 4.6 0.812
Total 22 ⁄ 554 4
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affect the results. The baseline prevalence of
carriage in the USA and Europe is reported to
be 5–10% [3,4,15]. In the UK, the highest carriage
rate (5–15%) is found among teenagers and
young adults, although the highest attack rate is
during the ﬁrst year of life (50 ⁄ 100 000) and
among teenagers (5 ⁄ 100 000) [3]. Of the 554
pupils who agreed to participate in the present
study, 4% were meningococcal carriers, a rate
slightly lower than that reported previously
among schoolchildren in Greece [10]. Although
the survey took place during the winter months,
Table 2. Risk factors for meningo-
coccal carriage in Greek schoolchil-
drenVariable Carrier Non-carrier
Odds ratio
(95% CI) p
Age > 12 years 19 186 11.78
(3.44–40.32)
< 0.0001
Immigrant 2 41 1.20
(0.27–5.30)
0.812
Preceding 4 263 0.23 0.008
infection (0.08–0.68)
Recent 1 112 0.18 0.094
antibiotics (0.24–1.34)
House 15 248 2.45 0.054
density > 1 (0.98–6.12)
One parent smoking 11 190 2.55
(0.80–8.15)
0.115
Both parents smoking 7 166 1.86 0.331
(0.53–6.45)
One parent 4 131 0.48 0.196
university-educated (0.16–1.46)
Both parents 2 150 0.21 0.039
university-educated (0.47–0.92)
Breast-feeding
‡ 3 months 10 184
(0.37–3.39)
1.13 0.827
< 3 months 7 244
(0.19–1.92)
0.60 0.387
Vaccination 3 42 1.84
(0.52–6.48)
0.341
Table 3. Multiple logistic regression analysis of risk fac-
tors associated with meningococcal carriage
Variable
Adjusted
odds ratio
95% Conﬁdence
interval p
Age > 12 years 7.96 2.24–28.33 0.001
Preceding viral illness 0.45 0.13–1.58 0.214
Recent antibiotic use 0.46 0.049–4.38 0.500
House density > 1 1.29 0.48–3.46 0.614
One parent
university-educated
0.68 0.21–2.23 0.528
Both parents
university-educated
0.42 0.09–1.98 0.275
Table 4. Serogroups and PFGE patterns of meningococ-
cal isolates
Isolate
no.
PFGE
strain type Serogroup
School
(classroom)
1 a NG S2 (c1)
5 a C S3 (c2)
17 a C S3 (c3)
18 a B S3 (c2)
19 a C S3 (c4)
11 a NG S3 (c3)
21 a C S3 (c5)
22 a B S3 (c6)
9 b D S3 (c7)
10 b C S3 (c7)
6 c NG S3 (c8)
20 c W135 S3 (c8)
4 d W135 S3 (c9)
8 d A S3 (c10)
2 DP B S2 (c1)
3 DP W135 S3 (c11)
13 ND NG S3 (c12)
14 ND C S3 (c9)
15 ND B S3 (c13)
16 ND B S3 (c4)
7 ND C S3 (c10)
12 ND NG S2 (c1)
NG, non-serogroupable; DP, distinct pattern; ND, not
done.
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when, as in most European countries, most cases
of meningococcal disease occur in Greece, it
cannot be assumed that this is the period with
the highest carriage rate, because such data are
not yet available.
Consistent with previous reports from northern
Europe [15,16], several factors such as age,
increased household density, parental education
and previous antibiotic use were associated with
carriage in Greek schoolchildren. Curiously, pre-
ceding viral infection was inversely related to
carriage, and passive smoking did not contribute
to carriage, as has been suggested previously [11].
Previous vaccination with either polysaccharide
A + C or conjugate C meningococcal vaccine did
not seem to affect carriage rates. This may be
attributed to the small proportion of vaccinated
children (8.1%), which was not enough to allow
the detection of any differences among vaccinated
and non-vaccinated individuals, or among poly-
saccharide vs. conjugate vaccine (one polysaccha-
ride and two conjugate vaccinees among carriers).
Other studies with much larger cohorts of indi-
viduals have shown a signiﬁcant reduction (66%)
in carriage rates following introduction of the
conjugate C vaccine, in two successive years [17].
As described elsewhere, only an age of > 12 years
remained a signiﬁcant variable following multi-
variate logistic regression analysis.
The small number of meningococcal isolates
tested in the present study does not permit
conclusions to be drawn about the prevalence of
penicillin resistance in this geographical region.
The percentage of isolates (22.7%) with interme-
diate penicillin resistance in the present study was
higher than that found in previous studies of the
same region (G. Tzanakaki, personal communica-
tion). This higher rate of penicillin resistance may
be an overestimate that can be explained by the
fact that three of the ﬁve strains exhibiting inter-
mediate resistance to penicillin had an identical
PFGE pattern and were isolated from children
attending the same school, thereby suggesting
spread of the same penicillin-resistant clone.
The distribution of serogroups showed that
most belonged to groups C (31.8%) and B
(22.7%). Genetic analysis by PFGE demonstrated
diversity among the isolates, although clusters of
isolates with identical PFGE patterns were noted
in one of the schools. Interestingly, more than one
serogroup was included in the same clonal group.
This ﬁnding supports a tentative suggestion that
switching of capsular genes may have occurred,
but analysis by an alternative typing method is
needed before this can be conﬁrmed.
Serogroup switching has been observed previ-
ously and may be induced by vaccination pres-
sure [18]. It is worth mentioning that three
carriers in the present study were vaccinated
with one of the two meningococcal vaccines. In
two of the three isolates from these carriers
(isolates 9 and 22; Table 4), switching of capsular
genes may have occurred. It is possible that the
increased level of herd immunity generated by
mass vaccination may force such escape mecha-
nisms and result in strain selection, colonisation
and disease outbreaks with serogroups not inclu-
ded in currently available vaccines.
The ﬁndings also demonstrated that the sero-
groups of meningococcal isolates from carriers
parallel the serogroups of pathogenic strains in the
same region [10]. Furthermore, it was observed
that pathogenic strains were genetically related to
isolates from carriers. Since asymptomatic carriers
are presumably the major source of transmission
of pathogenic strains, eradication of the carriage
state may result in a signiﬁcant reduction in
invasive meningococcal disease. It is well known
that the prevention of meningococcal disease by
eradication of the carriage state with antibiotics
might not ensure effective control of the disease.
There is published evidence that conjugate men-
ingitis C vaccines induce mucosal antibody,
resulting in a reduction in meningococcal C
carriage [18,19]. In view of the fact that serogroup
C represents a substantial proportion of isolates
from both carriage and disease, this vaccine might
be expected to prevent a signiﬁcant amount of
meningococcal disease in Greece.
In the absence of an effective vaccine against all
serogroups of N. meningitidis, a better understand-
ing of the dynamics of meningococcal carriage and
invasive disease will provide the scientiﬁc basis to
control this devastating illness. Meanwhile, it is
important to develop an optimal vaccination strat-
egywith the currently available vaccines in order to
prevent meningococcal disease.
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